Cardiol Therapeutics (CRDL.TO) Q2 2026 Earnings

11MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.12
-0.11
-0.1
-0.09

Details

Expected EPS
-0.088492078476
Actual EPS
-0.09832453163999999
Surprise EPS
-0.01
Surprise Percent
+11.11%

Description

Cardiol Therapeutics (CRDL.TO) has reported earnings of -0.09832453163999999 per share for Q2 2026.

0 Comments

Share your thoughts